英国生物银行中扩张型心肌病相关可能致病基因变异的频率、外显率与表现度
7.8%携带至少一个变异,临床扩张型心肌病占0.34%,早期特征占5.7%,亚临床证据额外占1.6%和15.9%,合并外显率≤30%。
要点
- 普通成人中7.8%携带扩张型心肌病基因可能致病变异,但临床外显率低。
- 携带者中约1/6有早期扩张型心肌病特征,最常见为心律失常或传导疾病。
- 亚临床扩张型心肌病特征需心电图和心脏磁共振识别,单纯临床诊断低估外显率。
核心结论
- 在英国生物银行成人中,约1/6携带扩张型心肌病基因可能致病变异者表现出与基因型相关的早期扩张型心肌病特征。
- 这些早期特征最常见为心律失常,而无明显心室扩张或功能障碍。
研究设计与样本
- 研究选取英国生物银行中完成全外显子测序、心电图和心脏磁共振的参与者。
- 采用1种主要和2种次要变异识别策略,在44个扩张型心肌病基因中识别可能致病变异。
主要发现
- 主要策略下1463例(7.8%)携带至少一个可能致病变异。
- 携带者中临床扩张型心肌病占0.34%,早期扩张型心肌病特征占5.7%。
- 心电图和心脏磁共振额外发现亚临床扩张型心肌病证据占1.6%,早期特征额外占15.9%。
- 心律失常或传导疾病最常见(15.2%),其次为运动减弱非扩张型心肌病(4%)。
- 三种策略合并临床/亚临床外显率均≤30%; definitive/strong证据基因的临床扩张型心肌病略多于moderate/limited证据基因。
关键数值与推荐
- 临床扩张型心肌病诊断率0.34%,早期特征5.7%,亚临床证据额外1.6%和早期特征额外15.9%。
- 心律失常或传导疾病占15.2%,运动减弱非扩张型心肌病占4%。
- 合并临床/亚临床外显率≤30%。
临床怎么用
- 对携带扩张型心肌病基因可能致病变异者,应结合心电图和心脏磁共振评估亚临床或早期特征。
- 心律失常或传导疾病可能是扩张型心肌病基因型携带者的早期表现,需关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a paucity of data regarding the phenotype of dilated cardiomyopathy (DCM) gene variants in the general population. We aimed to determine the frequency and penetrance of DCM-associated putative pathogenic gene variants in a general adult population, with a focus on the expression of clinical and subclinical phenotype, including structural, functional, and arrhythmic disease features. METHODS: UK Biobank participants who had undergone whole exome sequencing, ECG, and cardiovascular magnetic resonance imaging were selected for study. Three variant-calling strategies (1 primary and 2 secondary) were used to identify participants with putative pathogenic variants in 44 DCM genes. The observed phenotype was graded DCM (clinical or cardiovascular magnetic resonance diagnosis); early DCM features, including arrhythmia or conduction disease, isolated ventricular dilation, and hypokinetic nondilated cardiomyopathy; or phenotype-negative. RESULTS: Among 18 665 individuals included in the study, 1463 (7.8%) possessed ≥1 putative pathogenic variant in 44 DCM genes by the main variant calling strategy. A clinical diagnosis of DCM was present in 0.34% and early DCM features in 5.7% of individuals with putative pathogenic variants. ECG and cardiovascular magnetic resonance analysis revealed evidence of subclinical DCM in an additional 1.6% and early DCM features in an additional 15.9% of individuals with putative pathogenic variants. Arrhythmias or conduction disease (15.2%) were the most common early DCM features, followed by hypokinetic nondilated cardiomyopathy (4%). The combined clinical/subclinical penetrance was ≤30% with all 3 variant filtering strategies. Clinical DCM was slightly more prevalent among participants with putative pathogenic variants in definitive/strong evidence genes as compared with those with variants in moderate/limited evidence genes. CONCLUSIONS: In the UK Biobank, ≈1 of 6 of adults with putative pathogenic variants in DCM genes exhibited early DCM features potentially associated with DCM genotype, most commonly manifesting with arrhythmias in the absence of substantial ventricular dilation or dysfunction.
引用
- Shah RA, Asatryan B, Sharaf Dabbagh G, et al. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. Circulation. 2022. PMID: 35708014. doi:10.1161/CIRCULATIONAHA.121.058143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。